Sleep disturbance is frequently under-recognized in people with chronic obstructive pulmonary disease. The authors frame sleep problems as contributors to reduced health-related quality of life and note limited available data quantifying sleep quality and daytime sleepiness in routine COPD populations. This study aimed to determine the prevalence of poor sleep quality and daytime sleepiness among patients with COPD presenting to a tertiary care hospital and to describe relationships with disease burden and exacerbation frequency.
This was a cross-sectional observational study conducted from March to June 2025 at a tertiary care hospital. The study enrolled 398 patients with COPD. Sleep quality and daytime sleepiness were assessed using standardized, validated questionnaires: the Pittsburgh Sleep Quality Index (PSQI) for sleep quality and the Epworth Sleepiness Scale (ESS) for daytime sleepiness. The authors defined poor sleep quality as PSQI > 5 and excessive daytime sleepiness as ESS > 10. Clinical measures reported included COPD disease severity classification and the COPD Assessment Test (CAT) score.
Data management and analysis were performed using Microsoft Excel 2016 for data entry and SPSS version 20.0 for statistical analysis. The authors calculated point estimates with 95% confidence intervals and presented frequencies and percentages for categorical variables and mean ± standard deviation for continuous variables.
The manuscript reports that the study obtained institutional ethical oversight from the Institutional Review Committee of Kathmandu Medical College and that participant consent procedures were followed. The authors declared no competing interests.
A total of 398 patients with COPD were included. Key prevalence estimates reported by the authors were:
Regarding COPD burden and clinical status:
Sleep-specific quantitative results included a reduced mean sleep duration of 5.55 ± 0.80 hours. The authors also report prolonged sleep latency and commonly observed daytime dysfunction among participants.
Using the PSQI, more than half of the study population met criteria for poor overall sleep quality (PSQI > 5). The ESS identified nearly half of participants as having excessive daytime sleepiness (ESS > 10). The manuscript indicates specific component-level issues: delayed sleep onset (prolonged latency), shortened sleep duration (mean approximately 5.6 hours), and substantial daytime dysfunction, although detailed component scores beyond these summary observations were not provided in the abstract.
The authors report that both poor sleep quality and excessive daytime sleepiness were significantly associated with greater disease severity and higher exacerbation frequency. Patients with moderate-to-very severe COPD and those with frequent exacerbations had higher prevalence of disturbed sleep and daytime sleepiness. The study also documents a high symptom burden as reflected by the mean CAT score (24.36 ± 8.16).
In this cohort from a tertiary care setting, disturbed sleep was common: over half of patients had poor sleep quality and nearly half reported excessive daytime sleepiness. The investigators interpret these findings as clinically important given the associations with disease severity and exacerbation frequency. They suggest that routine screening for sleep problems should be incorporated into COPD care and that targeted interventions aimed at improving sleep, controlling respiratory symptoms, and reducing exacerbations may be warranted to improve health-related quality of life.
The authors emphasize the need to recognize sleep disturbance as a relevant comorbidity in COPD management and to consider structured assessment using tools such as PSQI and ESS.
This report is a single-center, cross-sectional observational study; causal inferences cannot be drawn from the design. The abstract does not report detailed demographic breakdowns, comorbidity profiles, medication use, or objective sleep studies (for example, polysomnography), and these details were not reported in the available source text. The authors state that Institutional Review Committee approval was obtained at Kathmandu Medical College and Teaching Hospital and that relevant participant consent procedures were completed. The authors declared no competing interests.
The authors note that all data produced in the study are available upon reasonable request. This manuscript is posted as a medRxiv preprint and has not been certified by peer review; the preprint notice emphasizes that the findings should not be used to guide clinical practice until peer-reviewed validation is available.